Sangamo BioSciences Announces Presentation At The 2015 Stem Cell Meeting On The Mesa

RICHMOND, Calif., Sept. 30, 2015 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO), a leader in therapeutic genome editing, announced today that Elizabeth Wolffe, Ph.D., Sangamo’s vice president of corporate communications, will provide an update on …

[Read the full article here]

Comments are closed.